Rieder R F, James G W
J Clin Invest. 1974 Oct;54(4):948-56. doi: 10.1172/JCI107835.
In contrast to findings in the thalasemia syndromes, studies of globin synthesis in subjects with structurally abnormal hemoglobins have generally revealed equal production of alpha and beta polypeptide chains. However, in the present investigation of globin biosynthesis in vitro in blood and marrow from two subjects heterozygous for unstable hemoglobin Leiden, beta6 or 7 Glu --> O, a significant excess of alpha-chain production was revealed. A mother and daughter of northern European ancestry with mild compensated hemolytic anemia were found to have 25% hemoglobin Leiden. Increased hemolysis occurred after the ingestion of a sulfonamide and during infections. Normal levels of hemoglobin A2, 3.0 and 2.7%, and hemoglobin F, 0.8 and 0.6%, were found in the two subjects. Similar percentages of the minor hemoglobins were demonstrated in other family members without hemoglobin Leiden. After incubation of peripheral blood with [(3)H]-leucine, the beta(A)/beta(Leiden) synthesis ratio was 1.3, and the specific activity of beta(Leiden) was 1.3-2 times beta(A). These results indicate preferential destruction of the unstable hemoglobin Leiden. However, in contrast to previous studies of other unstable hemoglobins, there was excess synthesis of alpha-chains. The total beta/alpha synthesis ratio was 0.47-0.63 in peripheral blood and 0.82 in marrow. A pool of free alpha-chains was demonstrated by starch gel electrophoresis and DEAE column chromatography. The synthesis of globin chains was balanced in family members without hemoglobin Leiden. This degree of predominance of alpha-chain synthesis in subjects with hemoglobin Leiden resembles the findings in heterozygous beta-thalassemia. However, the relatively normal hemoglobin content of the cells with this abnormal hemoglobin suggests the possibility of an absolute excess alpha-chain production in the hemoglobin Leiden syndrome.
与地中海贫血综合征的研究结果相反,对结构异常血红蛋白患者的珠蛋白合成研究通常显示α和β多肽链的产量相等。然而,在本次对两名血红蛋白莱顿(β6或7 Glu→O)不稳定型杂合子患者的血液和骨髓进行的体外珠蛋白生物合成研究中,发现α链产量显著过剩。一名具有北欧血统的母亲和女儿患有轻度代偿性溶血性贫血,发现她们有25%的血红蛋白莱顿。摄入磺胺类药物后以及感染期间溶血增加。两名患者的血红蛋白A2水平正常,分别为3.0%和2.7%,血红蛋白F水平正常,分别为0.8%和0.6%。在没有血红蛋白莱顿的其他家庭成员中也发现了相似比例的微量血红蛋白。用[³H] - 亮氨酸孵育外周血后,β(A)/β(莱顿)合成比率为1.3,β(莱顿)的比活性是β(A)的1.3 - 2倍。这些结果表明不稳定的血红蛋白莱顿被优先破坏。然而,与先前对其他不稳定血红蛋白的研究不同,α链有过量合成。外周血中总的β/α合成比率为0.47 - 0.63,骨髓中为0.82。通过淀粉凝胶电泳和DEAE柱色谱法证实存在游离α链池。在没有血红蛋白莱顿的家庭成员中,珠蛋白链的合成是平衡的。血红蛋白莱顿患者中α链合成的这种优势程度类似于杂合子β地中海贫血的研究结果。然而,含有这种异常血红蛋白的细胞中血红蛋白含量相对正常,这表明在血红蛋白莱顿综合征中可能存在绝对过量的α链产生。